During its life cycle, the unicellular parasite Entamoeba histolytica is challenged by a wide
variety of environmental stresses, such as fluctuation in glucose concentration, changes in gut …

Queuosine is a naturally occurring modified ribonucleoside found in the first position of the
anticodon of the transfer RNAs for Asp, Asn, His, and Tyr. Eukaryotes lack pathways to …

Entamoeba histolytica is the etiological agent of amebiasis, which is an endemic parasitic
disease in developing countries and is the cause of approximately 70,000 deaths annually. E. …

Amebiasis, a global intestinal parasitic disease, is due to Entamoeba histolytica. This
parasite, which feeds on bacteria in the large intestine of its human host, can trigger a strong …

Dicer is an RNase III enzyme that is responsible for the maturation of small RNAs such as
microRNAs. As Dicer’s cleavage products play key roles in promoting cellular homeostasis …

Entamoeba histolytica is an obligate protozoan parasite of humans, and amebiasis, an
infectious disease which targets the intestine and/or liver, is the second most common cause of …

Objective: Early compartment syndrome is difficult to diagnose, and a delay in the diagnosis
can result in amputation or death. Our objective was to explore the potential of infrared …

Adaptation of the Entamoeba histolytica parasite to toxic levels of nitric oxide (NO) that are
produced by phagocytes may be essential for the establishment of chronic amebiasis and the …

We have recently reported that Entamoeba histolytica trophozoites can adapt to toxic levels
of the nitric oxide (NO) donor, S-nitrosoglutathione (GSNO). Even if the consequences of this …

Metronidazole (MNZ), the first line drug for amoebiasis and auranofin (AF), an emerging
antiprotozoan drug, are both inhibiting Entamoeba histolytica thioredoxin reductase. The nature …